CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

BACKGROUND: Considering neoadjuvant chemotherapy (NAC) prior to surgery could shrink and reduce the primary tumor and distant micro-metastases to reduce the high relapses rates, NAC has been an accepted therapeutic management for patients with non-small cell lung cancer (NSCLC). CMTM1_v17 is highly...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Surg Oncol
Glavni autori: Si, Jiahui, Zhang, Panpan, Tian, Dan, Wang, Xing, Ma, Yuanyuan, Zhang, Jianzhi, Wang, Lu, Yang, Yue
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5273821/
https://ncbi.nlm.nih.gov/pubmed/28129775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1094-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items